Communities across Asia's Himalayan Hindu Kush region face heightened disaster risks this monsoon season with temperatures ...

A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...

Wildlife rescue teams scoured Australia's east coast on Monday to find and free a distressed humpback whale tangled in a rope ...

But the research is mixed, and experts still debate it. Weight loss can improve ... can treat the sleepiness that often comes with sleep apnea. Zepbound. It is a medicine for adults with obesity ...

"We have lots of options." CPAP or Zepbound? Patients, doctors debate sleep apnea treatment June 9 (UPI) A clash is brewing between doctors and patients when it comes to treatment for sleep apnea ...

Our guide will compare the benefits, side effects, cost, and dosage of the two medications in the raging Zepbound vs. Mounjaro debate. Learn how to get them ... joint pain, or sleep apnea. Its unique ...

Medicare drug plans can now cover Eli Lilly & Co.’s obesity drug Zepbound as a treatment for obstructive sleep apnea, news that’s expected to prove a big boost for the drug company.

Shelby Knowles / Bloomberg via Getty Images Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for sleep apnea last month. Weight loss ...

Eli Lilly's (NYSE:LLY) weight-loss drug Zepbound is now reportedly covered by Medicare for the treatment of obstructive sleep apnea in people with obesity. CNBC said Wednesday that the U.S ...

The U.S. Food and Drug Administration (FDA) has granted approval for Zepbound, a weight-loss medication, to treat moderate to severe obstructive sleep apnea (OSA) in individuals with obesity.

(NewsNation) — Zepbound became the first drug approved by the Food and Drug Administration to treat obstructive sleep apnea in obese adults earlier this month. “This is a major step forward for ...